A device described in a proof-of-concept study published in Biosensors and Bioelectronics uses portable lab-on-a-chip technology to accurately measure the concentration of Covid-19 antibodies present in diluted blood plasma.
Most nations have failed to employ large-scale antibody testing thus far, as the tests can be costly and need to be carried out in a lab by trained operators.
The lab-on-a-chip, which has been developed at the Okinawa Institute of Science and Technology, bypasses this need by combining powerful light-sensing technology with a microfluidic chip. The chip provides results within 30 minutes and is highly sensitive, detecting even the lowest clinically-relevant antibody concentration.
The devices are cheap to manufacture and do not need to be used in a lab or operated by specially trained personnel, increasing the feasibility of nationwide testing.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData